EURO SHOCK

Testing a novel treatment procedure for patients with cardiogenic shock

EURO SHOCK is a clinical trial aiming at improving the treatment for patients suffering from cardiogenic shock. The project focuses on the early use of a mechanical support device (ECMO), that can lend patients the support their heart needs to recover from a severe heart attack. EURO SHOCK is pan-European trial financed by the European Commission and is conducted following the highest ethical standards. The project has begun on January 2018, with recruitment of patients starting in October 2019.

FOR RESEARCHERS

Information about the aims and objectives of EURO SHOCK is available to researchers and medical doctors in the researchers' area.

enter researchers' area

FOR PATIENTS AND AFFILIATED

Information about cardiogenic shock and the clinical trial is available to patients and their families in the patients' area.

Enter Patients' area

NEWS

---

 NUMBERS 

332  

patients screened

35

patients
randomised

"EURO SHOCK is the largest clinical trial worldwide on the early use of ECMO in patients with cardiogenic shock”

- Prof. Anthony Gershlick,  Honorary Professor of Interventional Cardiology at the University of Leicester

EURO SHOCK PARTNERS

The following organizations are partners in the EU funded research project EURO SHOCK